Literature DB >> 30602758

Advances in patient care through increasingly individualized therapy.

Courtney D DiNardo1, Alexander E Perl2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30602758     DOI： 10.1038/s41571-018-0156-2

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  9 in total

1.  Development and validation of a prognostic model for adult patients with acute myeloid leukaemia.

Authors:  Ting-Ting Ma; Xiao-Jing Lin; Wen-Yan Cheng; Qing Xue; Shi-Yang Wang; Fu-Jia Liu; Han Yan; Yong-Mei Zhu; Yang Shen
Journal:  EBioMedicine       Date:  2020-11-22       Impact factor: 8.143

2.  Glasdegib in combination with low-dose Cytarabine for the outpatient treatment of relapsed or refractory acute myeloid leukemia in unfit patients.

Authors:  Andrius Zucenka; Kazimieras Maneikis; Birute Pugaciute; Ugne Ringeleviciute; Austeja Dapkeviciute; Linas Davainis; Guoda Daukelaite; Paulina Burzdikaite; Vytautas Staras; Laimonas Griskevicius
Journal:  Ann Hematol       Date:  2021-03-04       Impact factor: 3.673

3.  Functional Dependency Analysis Identifies Potential Druggable Targets in Acute Myeloid Leukemia.

Authors:  Yujia Zhou; Gregory P Takacs; Jatinder K Lamba; Christopher Vulpe; Christopher R Cogle
Journal:  Cancers (Basel)       Date:  2020-12-10       Impact factor: 6.639

4.  A novel fatty acid metabolism-related signature identifies features of the tumor microenvironment and predicts clinical outcome in acute myeloid leukemia.

Authors:  Hai-Bin Zhang; Zhuo-Kai Sun; Fang-Min Zhong; Fang-Yi Yao; Jing Liu; Jing Zhang; Nan Zhang; Jin Lin; Shu-Qi Li; Mei-Yong Li; Jun-Yao Jiang; Ying Cheng; Shuai Xu; Xue-Xin Cheng; Bo Huang; Xiao-Zhong Wang
Journal:  Lipids Health Dis       Date:  2022-08-25       Impact factor: 4.315

Review 5.  Alterations to DNMT3A in Hematologic Malignancies.

Authors:  Kartika Venugopal; Yang Feng; Daniil Shabashvili; Olga A Guryanova
Journal:  Cancer Res       Date:  2020-10-21       Impact factor: 13.312

Review 6.  CCAAT enhancer binding protein alpha (CEBPA) biallelic acute myeloid leukaemia: cooperating lesions, molecular mechanisms and clinical relevance.

Authors:  Anna S Wilhelmson; Bo T Porse
Journal:  Br J Haematol       Date:  2020-02-21       Impact factor: 6.998

7.  Timed sequential salvage chemotherapy for relapsed or refractory acute myeloid leukemia.

Authors:  Bogdan Popescu; Sheenu Sheela; Julie Thompson; Sophia Grasmeder; Therese Intrater; Christin B DeStefano; Christopher S Hourigan; Catherine Lai
Journal:  Clin Hematol Int       Date:  2019-12-09

Review 8.  New directions for emerging therapies in acute myeloid leukemia: the next chapter.

Authors:  Naval Daver; Andrew H Wei; Daniel A Pollyea; Amir T Fathi; Paresh Vyas; Courtney D DiNardo
Journal:  Blood Cancer J       Date:  2020-10-30       Impact factor: 11.037

9.  De novo individualized disease modules reveal the synthetic penetrance of genes and inform personalized treatment regimens.

Authors:  Taylor M Weiskittel; Choong Y Ung; Cristina Correia; Cheng Zhang; Hu Li
Journal:  Genome Res       Date:  2021-12-07       Impact factor: 9.043
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.